ArticleJournal of the neurological sciences2020
Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.
Article in Journal of the neurological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Toxicity of psychotropic drugs in patients with COVID-19: A systematic review.General hospital psychiatryPooled it
- Hyperthermia and targeting heat shock proteins: innovative approaches for neurodegenerative disorders and Long COVID.Frontiers in neuroscience · 2025Review
- Movement Disorders and SARS-CoV-2.Movement disorders clinical practice · 2023Article
- Article
- COVID19-associated new-onset movement disorders: a follow-up study.Journal of neurology · 2023Article
- Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis.Infectious agents and cancer · 2022Article
- Safety profile of COVID-19 drugs in a real clinical setting.European journal of clinical pharmacology · 2022Review
- Emerging Psychiatric Themes in Post-COVID-19 Patients on a Psychiatry Consultation-liaison Service.The Psychiatric quarterly · 2021Article
- Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic.European journal of neurology · 2021Observational
- De Novo Movement Disorders and COVID-19: Exploring the Interface.Movement disorders clinical practice · 2021Review
- A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome.The American journal of emergency medicine · 2021Article
- Myoclonus-Ataxia Syndrome Associated with COVID-19.Journal of movement disorders · 2021Article
- Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies.CNS drugs · 2021Review
- Disaster management of the psychological impact of the COVID-19 pandemic.International journal of emergency medicine · 2021Review
- New-Onset Movement Disorders Associated with COVID-19.Tremor and other hyperkinetic movements (New York, N.Y.) · 2021Review
- Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?European journal of pharmacology · 2020Review
Corrections and comments
- Comment on
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.